| ²é¿´: 534 | »Ø¸´: 1 | ||
jiangweilu½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖúÒ»¾äÓ¢ÎÄ·ÒëºÍ½âÊÍ£¬·Ç³£¸Ðл~ ÒÑÓÐ1È˲ÎÓë
|
|
ÇóÖú£¬ÇëÎÊÕâ¶Î»°¸ÃÔõô·Ò룬noninferiority criteriaÊÇʲô±ê×¼£¿Çó¸ßÊÖÖ¸µã£¬·Ç³£¸Ðл£¡ patients receiving liraglutide experienced a greater reduction in mean HbA1c compared with patients receiving exenatide QW (¨C1.48% and ¨C1.28%, respectively;treatment difference, 0.21% [95% CI, 0.08 to 0.33]), which did not meet the predefined noninferiority criteria (upper limit of CI, <0.25%). |
» ²ÂÄãϲ»¶
070303Ò»Ö¾Ô¸Î÷±±´óѧѧ˶310ÕÒµ÷¼Á
ÒѾÓÐ9È˻ظ´
0703»¯Ñ§µ÷¼Á£¬Çó¸÷λÀÏʦÊÕÁô
ÒѾÓÐ9È˻ظ´
0703»¯Ñ§µ÷¼Á
ÒѾÓÐ11È˻ظ´
0703»¯Ñ§ 305Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
274Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸Öк£Ñó²ÄÁϹ¤³Ìר˶330·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑоÀú
ÒѾÓÐ9È˻ظ´
¡¾Í¬¼ÃÈí¼þ¡¿Èí¼þ£¨085405£©¿¼ÑÐÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
267Ò»Ö¾Ô¸ÄϾ©¹¤Òµ´óѧ0817»¯¹¤Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çó¹ØÓڻƺӵÄÒ»¾ä»°µÄÓ¢ÎÄ·Ò룬¶ÔÄãÀ´Ëµ£¬Ò²ÐíºÜ¼òµ¥
ÒѾÓÐ6È˻ظ´
Ò»Ìâ10½ð£¬´ð°¸½âÊÍÒ»ÏÂΪʲô¡£¾¡Á¿Ó¢ÎĻشðлл
ÒѾÓÐ5È˻ظ´
ÇóÓ¢Óï´óÉñ·Òë
ÒѾÓÐ6È˻ظ´
·Òëthe bulk Òâ˼£¬·Ç³£¸Ðл
ÒѾÓÐ14È˻ظ´
רҵӢÓï·Òë¼±Óã¬Ð»Ð»´ó¼Ò~
ÒѾÓÐ3È˻ظ´
ÇóÖú±¾¿Æ»·ÆÀ±ÏÒµÂÛÎÄÕªÒªµÄÓ¢ÎÄ·Òë
ÒѾÓÐ4È˻ظ´
50½ð±Ò ÇóÖú·Òë
ÒѾÓÐ1È˻ظ´
ÇóÖú£¬¹ý¿Ø×¨ÒµÓ¢Óï·Òë
ÒѾÓÐ4È˻ظ´
ÇóÖúÖÐÎÄÕªÒª·Òë³ÉÓ¢ÎÄ¡£¡£¡£
ÒѾÓÐ12È˻ظ´
ºÏ³ÉÎÄÕÂÖеÄһЩӢÎÄËõд²»ÖªµÀʲôÒâ˼£¬·Ç³£¸Ðл
ÒѾÓÐ3È˻ظ´
Çë½ÌÒ»¾äÓ¢ÎÄ·Òë
ÒѾÓÐ4È˻ظ´
ÇóÖúÓ¢Óï¾ä×ӽṹ·ÖÎöºÍ·Òë
ÒѾÓÐ7È˻ظ´
ÇóÖú·ÒëÒ»¶ÎÓ¢ÎÄ
ÒѾÓÐ1È˻ظ´
Éó¸åÖеÄÒ»¾ä»°ÊÇʲôÒâ˼°¡£¬Ð»Ð»~
ÒѾÓÐ3È˻ظ´
ÇóÖúÈÕÓï·Ò룬лл£¡
ÒѾÓÐ6È˻ظ´
Çó·ÒëÒ»¾äÓ¢ÎÄ£¬ÎÒµÄÓï·¨ºÜ²î£¬ÇëÖ¸³ö¸Ã¾äÉæ¼°µÄÖ÷ÒªÓï·¨µã
ÒѾÓÐ11È˻ظ´
ÇóÖú´ß»¯¼Á²¿·ÖÓ¢ÎÄ·Ò룬¼±£¬¼±£¬¼±£¡
ÒѾÓÐ6È˻ظ´
ÇëÎÊÕâ¾äÓ¢ÎÄÊÇʲôÒâ˼£¿Ð»Ð»
ÒѾÓÐ8È˻ظ´
Çó¹¤×÷Æ·ÖʵÄÓ¢ÎÄ·Òë
ÒѾÓÐ6È˻ظ´
ÇëÎÊÕâ¾äÓ¢ÎÄÊÇʲôÒâ˼£¿ÔÚÏßµÈ
ÒѾÓÐ11È˻ظ´
ÇóÖú´¿ÕýÓ¢ÎÄ£¬ÎÒÀí½â²»ÁËÀÏÍâµÄÒ»¾ä»°Ê²Ã´Òâ˼£¬ÊÇ˵һÆðдÎÄÕ´øÉÏÎÒô£¿¡£¡£
ÒѾÓÐ4È˻ظ´
¡¾ÊéÕª¡¿¡¶Ëµ´Ê½â¾ä¡ª¡ªÓ¢ººÓïÑÔ¶Ô±ÈÓë·Òë¡· ¡ª¡ªÓ¢Óï½é´ÊʹÓó¡ºÏ£¨ÕªÂ¼£©
ÒѾÓÐ9È˻ظ´
ÇóÖú·ÒëÒ»¾äÓ¢ÎÄ£¬Ò©ÎïÁÙ´²Ñо¿·½ÃæµÄ£¬Ð»Ð»
ÒѾÓÐ6È˻ظ´
ÔÚÒ©ÎﻯѧÖÐ PK profile Ôõô·Òë ÊÇʲôÒâ˼°¡
ÒѾÓÐ11È˻ظ´
¿´²»¶®Ò»¾äÓ¢ÎÄ£¬Çó½âÊÍ£¬ÆøÖÊÁªÓÃÎÄÕÂÀïµÄ·½·¨ÎÄÕÂ
ÒѾÓÐ22È˻ظ´
klicking
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 923 (²©ºó)
- ¹ó±ö: 0.652
- ½ð±Ò: 19319.5
- É¢½ð: 30
- ºì»¨: 149
- ɳ·¢: 1
- Ìû×Ó: 2337
- ÔÚÏß: 513.3Сʱ
- ³æºÅ: 1426293
- ×¢²á: 2011-10-03
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
jiangweilu: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú, ·Ç³£¸Ðл 2015-03-09 14:55:03
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
jiangweilu: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú, ·Ç³£¸Ðл 2015-03-09 14:55:03
|
Ïà±È·þÓ㨸øÒ©£©°¬ÈûÄÇëÄQWµÄ»¼Õߣ¬·þÓ㨸øÒ©£©ÀûÀ³ëĵϼÕ߯½¾ùHbA1c¼õÉٵĸü¶à£¨·Ö±ðΪ-1.48%ºÍ-1.28%£»ÖÎÁƲîÒ죬0.21%[95% CI£¬0.08ÖÁ0.33]£©£¬Õâ²»·ûºÏÔ¤Ïȹ涨£¨È·¶¨£©µÄ·ÇÁÓЧ±ê×¼£¨CIÉÏÏÞ£¬<0.25%£©¡£ ¹ØÓÚnoninferiority criteria£¨·ÇÁÓЧ±ê×¼£©Çë²é¿´£ºhttp://wenku.baidu.com/link?url= ... Ku19zdvM3krSfxxBe67¡£ |

2Â¥2015-03-06 16:25:45













»Ø¸´´ËÂ¥